Surmodics Inc expected to post a loss of 31cents a share - Earnings Preview

SurModics

01/02/2022 16:50

* Surmodics Inc  SRDX.OQ   SRDX.O  is expected to show a
rise in
quarterly revenue when it reports  results on February 3. 
    * The Eden Prairie Minnesota-based  company is expected to
report 
a 6.3% increase in revenue to $23.707 million from $22.3 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Surmodics Inc is
for a
loss of 31 cents per share. For the same quarter last year, the
company reported earnings of 2 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Surmodics
Inc is
$72​, about 36.6% above​ its last closing price of $45.68. ​​​
    * 

This summary was machine generated February 1 at 16:50 GMT.  All
figures in US dollars  unless otherwise stated